comparemela.com

StockNews.com upgraded shares of Invitae (NYSE:NVTA – Free Report) from a sell rating to a hold rating in a research note published on Sunday morning. Other equities analysts also recently issued research reports about the stock. The Goldman Sachs Group dropped their price objective on shares of Invitae from $1.50 to $1.00 and set a […]

Related Keywords

United States ,Cambridge ,Cambridgeshire ,United Kingdom ,Canada ,Piper Sandler ,Metlife Investment Management ,Cambridge Investment Research Advisors Inc ,Advisor Group ,Cibc World Market Inc ,Aviva Plc ,Goldman Sachs Group ,Invitae Corporation ,Free Report ,Get Free Report ,Investment Research Advisors ,Life Investment Management ,World Market ,Invitae Daily ,Invitae ,Nyse Nvta ,Nvta ,Medical ,Upgrade ,Stocknews Com ,

© 2025 Vimarsana

comparemela.com © 2020. All Rights Reserved.